Bernd R. Seizinger - 14 Sep 2022 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role
Director
Signature
/s/ Leslie Auld as attorney-in-fact for Bernd R. Seizinger
Issuer symbol
APTOF
Transactions as of
14 Sep 2022
Net transactions value
$0
Form type
4
Filing time
16 Sep 2022, 17:32:52 UTC
Previous filing
16 Sep 2022
Next filing
23 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 14 Sep 2022 Common Shares 50,000 $0.7400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fifty percent (50%) of the options vest on September 14, 2023, twenty-five percent (25%) on September 14, 2024, and twenty-five percent (25%) on September 14, 2025.